glp-1 receptor agonist brand names Agonists are commonly used medications to treat Type 2 Diabetes. They are subcutaneous injections, so many patients mistaken these medications for insulin. However, GLP-1's are very different. They work primarily on Evolution of GLP‐1 Receptor Agonists

4 The burden of MASLD is projected to increase exponentially, with anticipated rises of 21% and 63% in cases of MASLD and MASH, respectively

Additionally, potential GLP-1RA side effects were assessed for comprehensive safety evaluation

6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease

With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad

Moreover, the reduced splanchnic blood flow could affect nutrient uptake or affect digestion (107) leads to uncertainty regarding effects on memory and cognitive functions

Serious complications like pancreatitis or gallbladder issues are rare but should prompt immediate consultation with a healthcare professional